158 related articles for article (PubMed ID: 2423427)
1. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.
Pignatelli M; Waters J; Brown D; Lever A; Iwarson S; Schaff Z; Gerety R; Thomas HC
Hepatology; 1986; 6(3):349-53. PubMed ID: 2423427
[TBL] [Abstract][Full Text] [Related]
2. Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon.
Freni MA; Ajello A; Spadaro A; Fava A; Calapristi I; Marafioti T; Alessi N; Resta ML; Ferraù O
Hepatogastroenterology; 1997; 44(17):1295-301. PubMed ID: 9356842
[TBL] [Abstract][Full Text] [Related]
3. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis.
Chu CM; Shyu WC; Kuo RW; Liaw YF
Hepatology; 1988; 8(3):712-7. PubMed ID: 3286466
[TBL] [Abstract][Full Text] [Related]
4. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C.
Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K
Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000
[TBL] [Abstract][Full Text] [Related]
5. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
Lau JY; Bird GL; Naoumov NV; Williams R
Dig Dis Sci; 1993 May; 38(5):888-95. PubMed ID: 7683263
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
Karino Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
[TBL] [Abstract][Full Text] [Related]
7. Different expression of HLA class I antigens in liver of children with chronic hepatitis B, evaluated by immunohistochemical method.
Calzia R; Marazzi MG; Campelli A; Piscopo R; Dorati M; Puppo F; Borgiani L; Canepa M
Adv Exp Med Biol; 1989; 257():225-35. PubMed ID: 2694819
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of HLA class 1 antigens on the hepatocytes of patients with chronic hepatitis B.
Manabe K; Yamada G; Nagashima H
Gastroenterol Jpn; 1986 Aug; 21(4):357-64. PubMed ID: 2429887
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical analysis of HLA class I antigens of the hepatocyte membrane in hepatitis B virus carriers].
Hou JL; Lou KX; Zhang L
Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):29-31, 61. PubMed ID: 2205450
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection.
Montano L; Miescher GC; Goodall AH; Wiedmann KH; Janossy G; Thomas HC
Hepatology; 1982; 2(5):557-61. PubMed ID: 7118068
[TBL] [Abstract][Full Text] [Related]
11. Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.
Ikeda T; Pignatelli M; Lever AM; Thomas HC
Gut; 1986 Dec; 27(12):1498-501. PubMed ID: 3804026
[TBL] [Abstract][Full Text] [Related]
12. Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.
Vladutiu AO
Immunol Commun; 1978; 7(4):371-82. PubMed ID: 352919
[TBL] [Abstract][Full Text] [Related]
13. Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis.
Nagafuchi Y; Scheuer PJ
Hepatology; 1986; 6(1):20-3. PubMed ID: 3510950
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA class I antigens in sera of patients with chronic hepatitis.
Sakaguchi K; Koide N; Takenami T; Matsushima H; Takabatake H; Ferrone S; Tsuji T
Gastroenterol Jpn; 1992 Apr; 27(2):206-11. PubMed ID: 1577226
[TBL] [Abstract][Full Text] [Related]
15. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R
Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.
Michalak TI; Hodgson PD; Churchill ND
J Virol; 2000 May; 74(10):4483-94. PubMed ID: 10775584
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha and gamma positive mononuclear cells and HLA antigen expression on hepatocyte membrane in the liver in chronic type B and non-A, non-B hepatitis.
Arao M; Kakumu S; Tahara H; Yoshioka K; Sakamoto N
Gastroenterol Jpn; 1989 Jun; 24(3):255-61. PubMed ID: 2501137
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
20. Is modulation of HLA display by interferon important in preventing the development of the chronic carrier state of hepatitis B virus in adults?
Thomas HC; Pignatelli M
Gastroenterol Clin Biol; 1985 Apr; 9(4):287-9. PubMed ID: 2581841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
